Spanish IPO pipeline hits €2bn

Probitas Pharma, the bio-pharmaceutical group, is planning to raise up to €500m ($593m) at its Madrid initial public offering this summer, taking the Spanish pipeline to nearly €2bn.

A spokeswoman for Probitas Pharma said the group was planning an initial offer worth between €400m and €500m but added that the company was still in the process of selecting banks.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump